These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21925108)

  • 1. Human cytomegalovirus escapes a naturally occurring neutralizing antibody by incorporating it into assembling virions.
    Manley K; Anderson J; Yang F; Szustakowski J; Oakeley EJ; Compton T; Feire AL
    Cell Host Microbe; 2011 Sep; 10(3):197-209. PubMed ID: 21925108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HCMV grabs a mechanism to escape neutralization.
    Eisenberg RJ; Cairns TM; Cohen GH
    Cell Host Microbe; 2011 Sep; 10(3):177-8. PubMed ID: 21925104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus Virions Shed in Urine Have a Reversible Block to Epithelial Cell Entry and Are Highly Resistant to Antibody Neutralization.
    Cui X; Adler SP; Schleiss MR; Arav-Boger R; Demmler Harrison GJ; McVoy MA
    Clin Vaccine Immunol; 2017 Jun; 24(6):. PubMed ID: 28404573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism for neutralizing activity by the anti-CMV gH/gL monoclonal antibody MSL-109.
    Fouts AE; Comps-Agrar L; Stengel KF; Ellerman D; Schoeffler AJ; Warming S; Eaton DL; Feierbach B
    Proc Natl Acad Sci U S A; 2014 Jun; 111(22):8209-14. PubMed ID: 24843144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Antibodies and Strain Polymorphisms on Cytomegalovirus Entry and Spread in Fibroblasts and Epithelial Cells.
    Cui X; Freed DC; Wang D; Qiu P; Li F; Fu TM; Kauvar LM; McVoy MA
    J Virol; 2017 Jul; 91(13):. PubMed ID: 28381568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralization of Diverse Human Cytomegalovirus Strains Conferred by Antibodies Targeting Viral gH/gL/pUL128-131 Pentameric Complex.
    Ha S; Li F; Troutman MC; Freed DC; Tang A; Loughney JW; Wang D; Wang IM; Vlasak J; Nickle DC; Rustandi RR; Hamm M; DePhillips PA; Zhang N; McLellan JS; Zhu H; Adler SP; McVoy MA; An Z; Fu TM
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28077654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.
    Boeckh M; Bowden RA; Storer B; Chao NJ; Spielberger R; Tierney DK; Gallez-Hawkins G; Cunningham T; Blume KG; Levitt D; Zaia JA
    Biol Blood Marrow Transplant; 2001; 7(6):343-51. PubMed ID: 11464977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virion Glycoprotein-Mediated Immune Evasion by Human Cytomegalovirus: a Sticky Virus Makes a Slick Getaway.
    Gardner TJ; Tortorella D
    Microbiol Mol Biol Rev; 2016 Sep; 80(3):663-77. PubMed ID: 27307580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Neutralizing Antibodies in CMV Infection: Implications for New Therapeutic Approaches.
    Sandonís V; García-Ríos E; McConnell MJ; Pérez-Romero P
    Trends Microbiol; 2020 Nov; 28(11):900-912. PubMed ID: 32448762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal Antibodies to Different Components of the Human Cytomegalovirus (HCMV) Pentamer gH/gL/pUL128L and Trimer gH/gL/gO as well as Antibodies Elicited during Primary HCMV Infection Prevent Epithelial Cell Syncytium Formation.
    Gerna G; Percivalle E; Perez L; Lanzavecchia A; Lilleri D
    J Virol; 2016 Jul; 90(14):6216-6223. PubMed ID: 27122579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of Cytomegalovirus Dense Bodies by Scalable Bioprocess Methods Maintains Immunogenicity and Improves Neutralizing Antibody Titers.
    Schneider-Ohrum K; Cayatte C; Liu Y; Wang Z; Irrinki A; Cataniag F; Nguyen N; Lambert S; Liu H; Aslam S; Duke G; McCarthy MP; McCormick L
    J Virol; 2016 Nov; 90(22):10133-10144. PubMed ID: 27581989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human monoclonal anti-cytomegalovirus (CMV) antibody (MSL 109): enhancement of in vitro foscarnet- and ganciclovir-induced inhibition of CMV replication.
    Nokta M; Tolpin MD; Nadler PI; Pollard RB
    Antiviral Res; 1994 May; 24(1):17-26. PubMed ID: 7944310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis.
    Maidji E; McDonagh S; Genbacev O; Tabata T; Pereira L
    Am J Pathol; 2006 Apr; 168(4):1210-26. PubMed ID: 16565496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of Immunoglobulin with Cytomegalovirus-Infected Cells.
    Aiba N; Shiraki A; Yajima M; Oyama Y; Yoshida Y; Ohno A; Yamada H; Takemoto M; Daikoku T; Shiraki K
    Viral Immunol; 2017 Sep; 30(7):500-507. PubMed ID: 28598267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative neutralizing potencies of antibodies suggest conservation as well as mechanistic differences in human cytomegalovirus entry into epithelial and endothelial cells.
    Qi Y; He L; Cui X; Hertel L; Freed DC; Fu TM; Kauvar LM; McVoy MA; Ruan Q
    Virol J; 2020 Apr; 17(1):50. PubMed ID: 32268919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding and neutralizing anti-cytomegalovirus activities in immune globulin products.
    Wang X; Xu Y; Scott DE; Murata H; Struble EB
    Biologicals; 2017 Nov; 50():35-41. PubMed ID: 29029807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralizing activity of saliva against cytomegalovirus.
    Saccoccio FM; Gallagher MK; Adler SP; McVoy MA
    Clin Vaccine Immunol; 2011 Sep; 18(9):1536-42. PubMed ID: 21795465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Roles of Host and Viral Antibody Fc Receptors in Herpes Simplex Virus (HSV) and Human Cytomegalovirus (HCMV) Infections and Immunity.
    Jenks JA; Goodwin ML; Permar SR
    Front Immunol; 2019; 10():2110. PubMed ID: 31555298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a high-throughput assay to measure the neutralization capability of anti-cytomegalovirus antibodies.
    Gardner TJ; Bolovan-Fritts C; Teng MW; Redmann V; Kraus TA; Sperling R; Moran T; Britt W; Weinberger LS; Tortorella D
    Clin Vaccine Immunol; 2013 Apr; 20(4):540-50. PubMed ID: 23389931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of cytomegalovirus (CMV)-specific polyfunctional CD8+ T-cells and antibodies neutralizing virus epithelial infection in the control of CMV infection in an allogeneic stem-cell transplantation setting.
    Giménez E; Blanco-Lobo P; Muñoz-Cobo B; Solano C; Amat P; Pérez-Romero P; Navarro D
    J Gen Virol; 2015 Sep; 96(9):2822-2831. PubMed ID: 26025872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.